161 related articles for article (PubMed ID: 10910907)
1. JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells.
Jacobs-Helber SM; Ryan JJ; Sawyer ST
Blood; 2000 Aug; 96(3):933-40. PubMed ID: 10910907
[TBL] [Abstract][Full Text] [Related]
2. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis.
Nagata Y; Todokoro K
Blood; 1999 Aug; 94(3):853-63. PubMed ID: 10419875
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin.
Shan R; Price JO; Gaarde WA; Monia BP; Krantz SB; Zhao ZJ
Blood; 1999 Dec; 94(12):4067-76. PubMed ID: 10590051
[TBL] [Abstract][Full Text] [Related]
4. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia.
Jacobs-Helber SM; Roh KH; Bailey D; Dessypris EN; Ryan JJ; Chen J; Wickrema A; Barber DL; Dent P; Sawyer ST
Blood; 2003 Jan; 101(2):524-31. PubMed ID: 12393629
[TBL] [Abstract][Full Text] [Related]
6. Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines.
Jacobs-Helber SM; Sawyer ST
Blood; 2004 Aug; 104(3):696-703. PubMed ID: 15059850
[TBL] [Abstract][Full Text] [Related]
7. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation.
Nagata Y; Takahashi N; Davis RJ; Todokoro K
Blood; 1998 Sep; 92(6):1859-69. PubMed ID: 9731042
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells).
Bao H; Jacobs-Helber SM; Lawson AE; Penta K; Wickrema A; Sawyer ST
Blood; 1999 Jun; 93(11):3757-73. PubMed ID: 10339482
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.
Xia Z; Dickens M; Raingeaud J; Davis RJ; Greenberg ME
Science; 1995 Nov; 270(5240):1326-31. PubMed ID: 7481820
[TBL] [Abstract][Full Text] [Related]
10. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.
Mansouri A; Ridgway LD; Korapati AL; Zhang Q; Tian L; Wang Y; Siddik ZH; Mills GB; Claret FX
J Biol Chem; 2003 May; 278(21):19245-56. PubMed ID: 12637505
[TBL] [Abstract][Full Text] [Related]
11. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
Park HJ; Kim BC; Kim SJ; Choi KS
Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Bcl-associated death protein (Bad) by erythropoietin-activated c-Jun N-terminal protein kinase 1 contributes to survival of erythropoietin-dependent cells.
Deng H; Zhang J; Yoon T; Song D; Li D; Lin A
Int J Biochem Cell Biol; 2011 Mar; 43(3):409-15. PubMed ID: 21095239
[TBL] [Abstract][Full Text] [Related]
13. Phosphatase inhibition promotes antiapoptotic but not proliferative signaling pathways in erythropoietin-dependent HCD57 cells.
Lawson AE; Bao H; Wickrema A; Jacobs-Helber SM; Sawyer ST
Blood; 2000 Sep; 96(6):2084-92. PubMed ID: 10979952
[TBL] [Abstract][Full Text] [Related]
14. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
Bose C; Udupa KB
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery.
Okano J ; Rustgi AK
J Biol Chem; 2001 Jun; 276(22):19555-64. PubMed ID: 11278851
[TBL] [Abstract][Full Text] [Related]
17. Involvement of mitogen-activated protein kinases in Group B Streptococcus-induced macrophage apoptosis.
Fettucciari K; Fetriconi I; Bartoli A; Rossi R; Marconi P
Pharmacol Res; 2003 Apr; 47(4):355-62. PubMed ID: 12644394
[TBL] [Abstract][Full Text] [Related]
18. Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter.
Bonfil D; Chuderland D; Kraus S; Shahbazian D; Friedberg I; Seger R; Naor Z
Endocrinology; 2004 May; 145(5):2228-44. PubMed ID: 14736735
[TBL] [Abstract][Full Text] [Related]
19. AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells.
Jacobs-Helber SM; Wickrema A; Birrer MJ; Sawyer ST
Mol Cell Biol; 1998 Jul; 18(7):3699-707. PubMed ID: 9632752
[TBL] [Abstract][Full Text] [Related]
20. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
